TABLE 1.
DapS/DapNS strain paira | Methicillin susceptibility | SNPs of DapNS strain |
Source and/or reference | ||
---|---|---|---|---|---|
mprF | yycG | rpoB/rpoC | |||
616/703 | MSSA | S295Lc | NDd | ND | 21 |
Q2819/Q2818 | MRSA | S337Lc | Nonee | None | 22 |
BOY755/BOY300 | MSSA | S295Lc | ND | ND | 30 |
CB5011/CB5012 | MRSA | L826Fb | None | ND | Cubist Pharmaceuticals, 25 |
CB5062/CB5063 | MRSA | None | None | None | Cubist Pharmaceuticals, 34 |
CB1663/CB1664 | MRSA | L826Fb | R86H | None | Cubist Pharmaceuticals, 34 |
All clinical strain pairs were bloodstream isolates.
Mutation in putative mprF synthase domain.
Mutation in putative mprF translocase domain.
ND, not determined.
None, no mutation determined.